More than £6.5million has been awarded to a University of Birmingham research project into liver diseases.
The Government announced the funding boost as part of a five year £800 million investment to advance medicines and treatments through universities and the NHS working together.
Birmingham researchers will team up with Queen Elizabeth Hospital, in Edgbaston, on pioneering work that includes trying to cure and prevent liver and pancreatic diseases.
Sir John Bell, president of the Academy of Medical Sciences, said: “The NHS in England has become one of the best environments in the world for undertaking cutting edge translational research.
“This is creating real opportunities for improving the health of patients, as well as positioning the UK as a preferred site for clinical development by the pharmaceutical and biotech industries.
“Much of this capability is the result of careful and strategic investment in research infrastructure by the National Institute of Health Research. The Biomedical Research Centres and Units are an excellent example of this investment and have transformed the relationship between hospitals and the research community.”
Queen Elizabeth Hospital chief executive Julie Moore said: “Our success in securing this funding is testament to the results of our excellent biomedical and translational research teams.
"It will allow us to build on our existing capacity, which can only benefit our patients and the wider NHS.
“The collaboration between the trust and the University of Birmingham makes us one of the few centres internationally that can complete the full circle of translational medicine. Through this partnership we are able to deliver internationally-recognised clinical programmes.”
